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Materials Science and kDepartment of Physics, Yale University, New Haven, ConnecticutABSTRACT Intrinsically disordered proteins (IDPs) are increasingly recognized for their important roles in a range of biological
contexts, both in normal physiological function and in a variety of devastating human diseases. However, their structural
characterization by traditional biophysical methods, for the purposes of understanding their function and dysfunction, has proved
challenging. Here, we investigate the model IDPs a-Synuclein (aS) and tau, that are involved in major neurodegenerative condi-
tions including Parkinson’s and Alzheimer’s diseases, using excluded volume Monte Carlo simulations constrained by pairwise
distance distributions from single-molecule fluorescence measurements. Using this, to our knowledge, novel approach we find
that a relatively small number of intermolecular distance constraints are sufficient to accurately determine the dimensions and
polymer conformational statistics of aS and tau in solution. Moreover, this method can detect local changes in aS and tau con-
formations that correlate with enhanced aggregation. Constrained Monte Carlo simulations produce ensembles that are in
excellent agreement both with experimental measurements on aS and tau and with all-atom, explicit solvent molecular dynamics
simulations of aS, with much lower configurational sampling requirements and computational expense.INTRODUCTIONA growing number of mammalian proteins are classi-
fied as natively unstructured or intrinsically disordered,
because they lack, in whole or part, stable native secondary
structure and tertiary interactions. Many in this class of
proteins are involved in signaling functions, where they
may act as hubs for information flow within the cell (1).
A number of IDPs are also directly implicated in a variety
of human diseases, ranging from cancer to Type II dia-
betes as well as a large spectrum of neurodegenerative disor-
ders (2).
In solution, IDPs populate an ensemble of rapidly inter-
converting structures, with the relative populations of the
various structures determined by the balance between
residue-residue interaction energies and chain entropy.
IDPs thus span a continuum of dynamic behavior between
well-folded proteins that assume a single native state repre-
senting a global minimum in the conformational energy
landscape (3), and ideal random coils that lack spatial or
temporal correlations between residues (4). CharacterizingSubmitted January 19, 2012, and accepted for publication September 17,
2012.
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0006-3495/12/11/1940/10 $2.00the partially ordered and disordered structures sampled by
IDPs remains a challenging problem.
A variety of biophysical techniques have been used to
provide indirect structural insight into IDPs (5). Specifically,
circular dichroism and infrared spectroscopic techniques
can probe the fractions of IDP residues involved in transient
a-helical or b-strand secondary structures (6). NMR and
electron paramagnetic resonance can provide information
on the local chemical environment around particular resi-
dues, as well as on mean inter-residue distances and relative
orientations (5,7). Fluorescence spectroscopy can probe
similar interresidue distances, as well as the dynamics of
conformational change and reconfiguration within the solu-
tion-state ensemble (8). SAXS or SANS (7) and diffusion-
based measurements (9,10) can provide measures of global
dimension, such as the radius of gyration (Rg) or hydrody-
namic radius (Rh).
Computational approaches have also been frequently
employed to study IDP conformational ensembles. Most
attempts to simulate IDPs involve one of two approaches:
1), MD simulations and enhanced-sampling variants
(11–13), in which a physical representation of a protein
chain evolves over time according to Newtonian equations
of motion; and 2), stochastic conformational searches in
which MC-type algorithms are used to efficiently sample
conformations of the protein chain (14). Both types of
approaches can be applied to all-atom representations of
proteins and solvent, or to models coarse-grained at varying
levels of spatial and temporal resolution. The solvent can be
represented either as a set of implicit corrections to protein-
protein interactions, or as explicit molecules (15,16).http://dx.doi.org/10.1016/j.bpj.2012.09.032
Conformational Ensembles of aS and Tau 1941Simulated ensembles are also sensitive to the choice of the
protein force field. An important caveat is that these force
fields are typically parameterized to reproduce the behavior
of folded proteins rather than IDPs, and thus they may fail to
capture important aspects of IDP ensembles (17–20).
a-Synuclein (aS; Fig. 1 a) is a 140-residue protein whose
aggregation is linked directly to the development and path-
ogenesis of Parkinson’s disease. Tau (Fig. 1 b) is a microtu-
bule-associated protein up to 441 residues long (subject to
alternative splicing) that forms characteristic neuronal
aggregates in several human disorders collectively called
tauopathies, including Alzheimer’s disease, Pick’s disease,
and chronic traumatic encephalopathy. Both aS and tau
are intrinsically disordered in their unbound monomeric
states, but can self-assemble into a variety of partially or
highly ordered oligomeric and fibrillar aggregates. Both
proteins are subjects of significant interest, not only because
of their clinical relevance but also as models for other IDPs
that self-assemble into amyloid aggregates. The solution-
state ensembles of aS and tau have been studied by NMR
(21–25), fluorescence (26–32), SAXS (33–39), and a variety
of computational methods (13,23,40–43). Despite this
extensive effort, there is significant disagreement about
even the most fundamental structural properties of these
proteins in solution (e.g., reported Rg values for aS vary
nearly twofold, from 2.6 nm (34) to 5.0 nm (36)), possibly
due to aggregation or oligomerization in solution at theFIGURE 1 (a) Schematic of 140-residue aS in solution. Residues 60–95
form the core of amyloid fibrils, whereas residues 1–95 form an amphi-
pathic helix in the presence of anionic lipid membranes. The N-terminal
region (NT) bears a net positive charge, whereas the C-terminus (CT) is
highly negatively charged at pH 7.4 but neutral at pH 3.0. (b) Schematic
of the 441-residue isoform of tau. The microtubule-binding region
(MTBR; residues 244–369) forms the core of amyloid aggregates and is
also the putative binding site for the molecular aggregation inducer heparin,
whereas residues 151–243 (Pro) are rich in prolines.concentrations (30–800 mM) necessary for SAXS and
NMR experiments. Fluorescence techniques such as
smFRET circumvent these complications by using much
lower protein concentrations (~50 pM), but provide qualita-
tively lower resolution data. Given that IDPs are in-
creasingly recognized as viable pharmacological targets
(44–46), smFRET may also be particularly well suited to
drug candidate screening: the low protein concentrations
used should enable the accurate identification of compounds
that alter the target conformation by binding with very high
affinity (KDs as low as ~500 pM). On the computational
side, MD studies of aS in solution have typically required
nonphysiological temperatures (40,41) to generate Rg and
Rh values that agree with experiments. Although fragments
of tau have been studied by all-atom MD (47,48), the full-
length protein is too long (441 residues) for meaningful
simulations to be run at reasonable computational expense
with current resources. More consistent results have been
obtained for both aS and tau by post facto filtering of an
unconstrained ensemble to fit experimental data (23,43)
and using coarse-grained MC approaches (49).
In this work, we describe computational studies based on
our extensive experimental smFRET measurements that
provide a quantitative description of aS and tau solution-
state conformations. We first develop an ECMC method
to incorporate long-range pairwise distance constraints
from smFRET into MC simulations, and find that remark-
ably few constraints are sufficient to reproduce the global
dimensions of aS and tau found experimentally under
various conditions. For aS, we find that AAMD simulations
in explicit solvent accurately capture the average pairwise
interresidue distances of aS in solution, albeit at signifi-
cantly higher computational cost than ECMC. The larger
size of tau makes the computational cost for analogous
AAMD simulations impractically high. Finally, uncon-
strained UMC simulations that include dihedral angle
potentials, hydrogen bonding, effective residue-residue,
and residue-environment interactions tuned to match the
global dimensions of aS also matched the AAMD en-
semble and smFRET observations in terms of polymer
scaling behavior and mean interresidue distances. Both
UMC and AAMD show large fluctuations about these
mean distances that may be important in determining the
populations of aggregation-prone states. The ECMC tech-
nique can be generalized to other unstructured proteins
and will enable efficient characterization of the native state
ensembles of IDPs, and of the conformational changes
produced by environmental factors, covalent modifica-
tions, and small-molecule modulators of function and
dysfunction.MATERIALS AND METHODS
Details on smFRET data collection, constraint generation, and resampling-
based error estimation procedures are provided in the Supporting Material.Biophysical Journal 103(9) 1940–1949
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All MC calculations were implemented using the PyRosetta (50) and
Scientific Python libraries for Python on Yale University High Performance
Computing clusters. aS and tau were modeled with all backbone atoms rep-
resented explicitly, and each side chain represented by a single bead located
at the centroid of the appropriate atoms. For the ECMC simulations, the
effective potential consisted of purely repulsive Lennard Jones (LJ) interac-
tions and harmonic restraints with mean distances and variances derived
from smFRET measurements (27,51) as detailed in the Supporting
Material. For the UMC simulations, the potential included the pair (statis-
tical residue-residue interaction), env (statistical residue-environment
interaction), rama (backbone dihedral propensities), hbond_sr_bb and
hbond_lr_bb (short- and long-range backbone hydrogen bonding, respec-
tively) terms of the Rosetta force field, each with equal weights. The confor-
mational sampling involved ~106 backbone moves for each model, with the
effective temperature decreased from 10 kbT to the final target temperature
(0.1 kbT for ECMC, varied for UMC) over the course of the refinement.
Ensembles of at least 400 different structures were generated for each set
of parameters.AAMD simulations
We performed AAMD simulations of aS in explicit water using the fixed
NPT ensemble (also known as the isobaric-isothermal ensemble, i.e., with
the number of particles, pressure, and temperature held constant) at temper-
ature T¼ 293 K and pressure P¼ 1 bar, conditions which closely match the
smFRET experiments, to measure the solution-state ensemble of aS.
These simulations were implemented in Gromacs 4.5.1 (52) using the
Amber99SB (53,54) force field with the TIP4P-Ew water model (55).
This parameter set produced markedly better agreement with ECMC Rg
values in preliminary simulations than other combinations of force field
and solvent model (not shown), and has also been reported to provide supe-
rior accuracy in protein simulations (17–19,56,57), especially in describing
flexible protein regions (56). Pressure was controlled by the weak coupling
method (58) with a 1.0 ps coupling time and temperature by a stochastic
velocity distribution thermostat of Bussi et al. (59) that yields the canonical
distribution with a 0.1 ps coupling time. The temperature of the protein was
controlled independently of the solute and ions. Consistent with the original
Amber99SB force field parameterization (53), nonbonded interactions were
cutoff at 0.8 nm and the particle mesh Ewald method was employed to
calculate the long-ranged electrostatic interactions. A time step of 2 fs
and a cubic simulation box with volume (11 nm)3 were used for all simu-
lations. The simulation volume is very large, but it is possible even with
this box size for a completely extended protein configuration to interact
with itself under periodic boundary conditions. However, such events are
rare and were not included in the analysis. Ten different initial configura-
tions randomly selected from the end states of ECMC simulations were
run for a total of 574 ns. This ensured independent simulation trajectories
for improved configurational sampling. The initial 10 ns of each trajectory
were omitted from the analysis to allow for structural relaxation, leaving
a total of 474 ns of simulation time used to generate the AAMD ensemble.RESULTS
ECMC simulations
SmFRET uses the efficiency of energy transfer between two
labeled residues in a protein chain as a sensitive probe of
protein conformation on the nm scale. We previously re-
ported ETeff values between 12 pairs of residues in aS
(27,51), and have also recently measured analogous ETeff
between 12 residue pairs in tau (60). These data sets eachBiophysical Journal 103(9) 1940–1949represents the most extensive set of interresidue distances
measured on aS and tau, respectively, at the single-molecule
level. In the case of dynamic random coils like aS and tau,
the use of polymer models, which reflect the ensemble of
conformations sampled by the protein on the timescale of
smFRET measurements (~1 ms), has been shown to lead
to more accurate calculations of distances from ETeff than
the simple application of the Fo¨rster equation (61–63). We
used results from excluded volume MC simulations to
convert the smFRET measurements of ETeff into distance
constraints, as detailed in the Supporting Material.
For all MC simulations, the proteins were modeled using
the centroid representation of Rosetta (64), which consists
of an all-atom peptide backbone and a single-bead pseudoa-
tom for each residue side chain (accounting for side-chain
size, and the location of the average center of mass of
favorable side-chain conformations). We performed a MC
conformational search implemented in the PyRosetta soft-
ware package (50,64), with only smFRET-derived con-
straints and purely repulsive LJ interactions included in
the potential, using up to 5  106 backbone moves. From
this ensemble of structures produced by the ECMC simula-
tions, we generated Rg distributions, interresidue dis-
tance maps, and the scaling behavior of the interresidue
distance with sequence separation. Totals of 106 and 5 
106 backbone moves were sufficient to ensure convergence
of these three structural characteristics for aS and tau,
respectively. These protocols were used for all subsequent
simulations.
To study the effects of harmonic constraints on aS en-
sembles, we performed ECMC with various subsets of
the constraints derived from smFRET measurements at
pH 7.4. The mean Rg decreased from 5.15 0.9 nm without
constraints (the excluded volume random-coil limit for the
aS chain), to 3.3 5 0.3 nm for the fully constrained
ensemble (Fig. 2 a). This compaction relative to a random
coil involves enhanced local contacts between the N- and
C-terminal regions of aS (Fig. 2 b). Polymer conformational
statistics are frequently described in terms of the relation
between mean interresidue distance r and sequence separa-
tion N:
r ¼ CNn; (1)
where n is the Flory scaling exponent, and the prefactor C
depends roughly on the size of the monomer unit. The aS
ensemble obtained by ECMC possesses a mean scaling
exponent of 0.39 (Fig. 2 c), intermediate between the expo-
nents expected for an excluded volume random coil (0.59)
and a compact globule (0.33), which suggests the presence
of attractive interactions within the disordered aS chain.
An important caveat is that the scaling laws in polymer
theories apply in the long chain limit; whereas aS and tau
have chain lengths of 140 residues and 441 residues, respec-
tively. We are using the scaling form of the interresidue
FIGURE 2 (a) Mean Rg values obtained by ECMC using between 0 and 12 randomly selected smFRET-derived constraints of aS. Gray circles and
associated vertical lines indicate means and standard deviations of distributions obtained from a single randomly selected subset of the full constraint
set, with the number of constraints indicated on the horizontal axis. Black circles denote means over all subsets for a given number of constraints. (b)
An interresidue distance difference map shows the change in mean interresidue distances between the unconstrained random coil ensemble and ECMC-
derived aS ensemble at pH 7.4. The black contour separates regions that display compaction (Dr < 0) relative to the random coil from those that display
expansion (Dr> 0); compaction is particularly evident between residues 1–30 and 100–140. (c) The ECMC-derived aS ensemble (solid line) shows a polymer
scaling intermediate between the excluded volume random-coil limit (obtained from unconstrained MC simulations of aS with purely repulsive LJ interac-
tions and no smFRET constraints) and a compact globule (C ¼ 0.38 nm, n ¼ 0.33 for Eq. 1 in the text), both shown as dotted lines. The light shaded area
indicates the standard deviation in ECMC-derived r values, obtained by resampling error estimation as described in the Supporting Material. Points are
discrete values obtained by smFRET (triangles), tryptophan triplet-state lifetime (65) (circles), and time-resolved FRET (29) (squares) measurements.
Black and gray dashed lines are fits of Eq. 1 to the ECMC data for N < 40 and N > 40, respectively. The inset shows data replotted on logarithmic
axes. (d) Rg histograms obtained by ECMC of aS at pH 7.4 (Rg ¼ 3.3 5 0.3 nm) and pH 3.0 (3.2 5 0.3 nm), compared with the excluded volume
random-coil model (5.1 5 0.9 nm). Low pH, which enhances aS aggregation, has a minor effect on Rg. (e) Distance difference map (pH 3.0 – pH 7.4)
showing the detailed effect of acidic environments on aS conformation, most notably compaction (Dr < 0) of the C-terminus and core regions.
Conformational Ensembles of aS and Tau 1943separation in Eq. 1 as an empirical characterization of the
size of aS and tau.
Major sources of uncertainty in smFRET are experi-
mental error in the determination of ETeff (estimated to
be ~1–2% for our instrumentation based on repeated
smFRET measurements of a standard sample), and varia-
tion in the Fo¨rster radius due to anistropic dye tumblingand/or changes in quantum yield (estimated to be 7–8%
based on fluorescence lifetime and anisotropy mea-
surements). We implemented a resampling error estima-
tion protocol described in the Supporting Material to
quantify the resulting uncertainties in ECMC results,
which are represented by the shaded area in Fig. 2 c. Due
to the redundant nature of smFRET-derived constraints,Biophysical Journal 103(9) 1940–1949
1944 Nath et al.the standard error of the mean in ensemble properties such
as Rg or n is ~1.5%.
ECMC using smFRET measurements of aS at pH 3.0,
a condition that is known to accelerate aggregation
(27,67), indicates a slight compaction in terms of the
mean Rg (3.25 0.3 nm) relative to the neutral-pH ensemble
(Fig. 2 d). However, the low-pH ensemble shows significant
changes in the pattern of mean interresidue distances, with
decreased contact between the N-terminus and the central
region, and increased contact between the C-terminus and
much of the rest of the protein (Fig. 2 e).
Similarly, we compared smFRET distance measurements
between 12 residue pairs (60) for tau, in the presence and
absence of the polyanion heparin, which is known to
dramatically enhance the aggregation rate of tau in solution.
Like aS, tau displays a progressive compaction relative to
an excluded volume random coil of equal length (Rg ¼
10.9 5 1.9 nm) as the number of constraints is increased
(Fig. S2). The mean Rg of tau increases from 5.1 5
0.5 nm to 6.0 5 0.6 nm upon the addition of heparin (see
Fig. 3 b), whereas the corresponding Rh values calculated
by Hydropro (68) increase from 5.3 5 0.3 nm to 5.9 5
0.5 nm. In the absence of heparin, tau demonstrates a poly-
mer scaling intermediate between the random coil and
globule limits at small and medium sequence separations,
but is markedly more compact at larger separations, so
that the overall mean scaling exponent is 0.27. Heparin
eliminates this long-range compaction, increasing the
mean value of n to 0.44 (Fig. 3 a). This expansion, particu-
larly evident between residues 1–50 and the span from resi-
dues 180–441, is partially offset by compaction between
residues 140–220 and residues 340–420 (Fig. 3 c).FIGURE 3 (a) Tau in buffer (- Heparin) displays similar polymer scaling
behavior to aS at short and medium sequence separations, between the
random coil and globule limits (dotted lines), but displays marked com-
paction at long sequence separations. The addition of heparin eliminates
this long-range compaction, resulting in an increase in the mean scaling
exponent from 0.28 to 0.43. (b) The global expansion induced by heparin
is reflected in an increase in Rg from 5.1 5 0.5 nm to 6.0 5 0.6 nm,
compared to 10.9 5 1.9 nm for an excluded volume random-coil.
(c) A distance difference map (heparin - buffer only) reveals that this global
expansion is partially compensated for by a compaction of the proline-rich
and microtubule-binding regions of tau in the presence of heparin. The
black contour separates regions that display compaction (Dr < 0) from
those that display expansion (Dr > 0).Unconstrained MC and AAMD simulations
To further test the relation between Rg and interresidue
distances, we investigated how accurately unconstrained
simulations that reproduce the global dimensions of aS
could predict the mean smFRET-derived distances. UMC
simulations using a more complete Rosetta potential were
performed over a range of effective temperatures to identify
conditions that best reproduced the mean Rg obtained by
ECMC. The potential used for UMC simulations included
statistically obtained residue-environment and residue-
residue interaction terms, backbone dihedral angle pro-
pensities, backbone hydrogen-bonding, and repulsive LJ
interaction terms, reflecting charge interactions, hydropho-
bicity and polarity, and the sterics of the protein backbone.
The UMC ensemble at 1.2 kbT most accurately captured the
mean Rg of aS at neutral pH, and the mean interresidue
distances extracted from this ensemble were in excellent
agreement with the corresponding distances measured by
smFRET (Fig. 4 a). We further performed all-atom,
explicit-solvent MD (AAMD) on aS using the Amber99SB
(53,54) force field with the TIP4P-Ew water model (55) atBiophysical Journal 103(9) 1940–1949293 K. This combination of parameters produces an en-
semble with a Rg of 3.1 5 0.9 nm, in close agreement
with mean experimental values, and reproduces the mean
FIGURE 4 (a) Experimentally derived interresi-
due distance distributions from ECMC of aS (dark
gray histograms with means indicated by black
lines) and corresponding distributions from uncon-
strained simulations (left panel:UMC; right panel:
AAMD; light gray histograms with means indi-
cated by gray lines). Both simulation techniques
accurately capture the mean pairwise distances
but predict broader distance distributions, given
either no experimental information (in the case of
AAMD), or only the Rg (in the case of UMC).
Note that AAMD distance distributions appear to
be multimodal, especially for residue pairs span-
ning the N- and C-terminal regions of aS. (b) Rg
distributions from UMC and AAMD simulations
match the mean (3.3 nm) from ECMC, but have
greater width (cf. Fig. 2 d). (c) Distance difference
maps comparing a random coil simulation with
UMC (top) and AAMD (bottom) ensembles closely
resemble each other, and the analogous map for
ECMC simulations (cf. Fig. 2 b).
Conformational Ensembles of aS and Tau 1945interresidue distances measured by smFRETwith high accu-
racy (Fig. 4 a). The ensemble generated by AAMD resem-
bles that produced by UMC simulations (Fig. 4, b and c),
but the computational cost is significantly higher. Properties
of the ensembles generated by AAMD, UMC, and ECMC
are compared in greater detail in the Supporting Material.DISCUSSION
ECMC simulations
The ECMC protocol we have developed here is an efficient,
powerful probe of aS and tau global dimensions, polymer
scaling behavior, and local contacts. ECMC accurately
reproduces the global dimensions of aS given pairwise
distances from smFRET experiments: the mean Rg
decreases smoothly and asymptotes to the experimental
value as the number of constraints increases, which indi-
cates that the smFRET data are internally self-consistent.
Remarkably, as few as two or three constraints are enough
to capture much of the compaction of aS, even though the
only other term in the effective potential for these simula-
tions is the repulsive LJ interaction. The measurement of
Rg by ECMC (3.3 nm) lies within the broad range (2.6
to 5.0 nm) suggested by previous SAXS experiments(33–36), but is substantially more precise than these
ensemble measurements (see details of error estimation in
the Supporting Material). We recently measured the Rh
value of aS to be 2.745 0.04 nm using pulsed field gradient
NMR (69). The Rg/Rh ratio of aS is therefore ~1.2, in excel-
lent agreement with the analogous ratio measured for
unfolded protein L using smFRET and fluorescence correla-
tion spectroscopy (62).
The polymer scaling behavior of aS as determined by
ECMC also recapitulates very closely the results of trypto-
phan triplet-state lifetime (65) and time-resolved FRET
(29) experiments, even at small sequence separations where
the interresidue distances are too short for direct measure-
ment by smFRET. We find that the scaling behavior depends
on sequence separation, with the Flory exponent n changing
from ~0.59 for N < 40 to ~0.34 for N > 40. The intriguing
observation that the scaling exponent for aS shifts from
nearly the self-avoiding random-coil value to the globule
value as sequence separation increases may reflect the fact
that the intrinsic stiffness and excluded volume properties
of the polypeptide backbone predominate at small N,
whereas intramolecular attractive interactions predominate
at large N. The long-range contacts that cause this compac-
tion in the ECMC ensembles resemble those observed in
PRE NMR experiments (21,23) and numerical simulationsBiophysical Journal 103(9) 1940–1949
1946 Nath et al.(43), particularly in terms of the enhanced contacts between
residues 1–30 and 100–140 (23,43). Approximately 11% of
the structures in the ECMC ensemble display end-to-end
distances below 5 nm. The interresidue distance distribu-
tions obtained from ECMC simulations appear largely un-
imodal (red histograms in Fig. 4 a).
The polymer scaling of tau in the absence of heparin is
qualitatively similar to that of aS, with a progressive
compaction with increasing N: the exponent n changes
from ~0.60 for N < 40, to ~0.39 for 40 < N < 140, and
then to ~0.09 for N > 140. This marked deviation from
excluded volume power-law scaling behavior at high
sequence separations to scaling that is below the theoretical
globule limit may reflect specific interactions between the
N- and C-termini of tau as suggested by Mandelkow and
co-workers (31,32) and also observed by PRE NMR (25).
Heparin has a dramatic effect on this behavior: the exponent
n changes from ~0.62 for N < 40, to ~0.43 for N > 40,
whereas the hypercompaction at high N is eliminated.
This expansion is also reflected in the Rg and calculated
Rh values of tau, which increase by 19% and 11%, respec-
tively, in the presence of heparin. The latter change is in
excellent agreement with fluorescence correlation spectros-
copy experiments, which show a 14% increase in the diffu-
sion time upon binding of heparin (60).
ECMC is also sensitive to local changes in structure that
do not have a major effect on global dimensions. Although
decreasing the pH from 7.4 to 3.0 results in only small
changes in aS Rg (3.3 nm vs. 3.2 nm), the two ECMC
ensembles are significantly different in local structure.
The decreased charge on the C-terminus at low pH leads
to a marked collapse of this region, and enhanced inter-
actions with residues 25–100. This span includes the aggre-
gation prone region (residues 60–95) of aS, and so this
altered interaction may relate to the increased aggregation
propensity of aS at low pH. There is a compensatory
expansion of the N-terminus that may be due to the
increased net positive charge of this region in acidic envi-
ronments. This observation agrees very well with PRE
NMR experiments on aS at low and neutral pH (23,41),
which also show a relative collapse of the C-terminus and
slight expansion of the N-terminus. Similarly, although
the addition of heparin caused a moderate increase in the
global dimensions of tau, this masks a compaction of the
central microtubule-binding region that forms the core of
tau-derived amyloid aggregates. Heparin also eliminates
the long-range contacts between the termini of tau that
have been previously observed by ensemble FRET
(31,32). These conformational changes may be driven by
neutralization of the net positive charge on the proline-
rich and microtubule-binding regions of tau by the polyan-
ion heparin. Our results illustrate the ability of ECMC to
effectively identify local changes in structure, even in the
absence of major global changes, which could provide
crucial insight into the environmental factors and bindingBiophysical Journal 103(9) 1940–1949partners that affect the tendency of aS and tau to patholog-
ically self-assemble.UMC and AAMD simulations
Having demonstrated that ECMC accurately reproduces
global dimensions from pairwise constraints, we addressed
the inverse problem of whether it is possible to derive
pairwise interresidue separations from global dimensions
of the chain. UMC simulations with a single free parameter
(effective temperature) tuned to match the mean Rg accu-
rately reproduced mean interresidue distances that span
nearly the complete sequence of aS. The polymer scaling
behavior and interresidue distance map of the UMC
ensemble also resemble those of the ECMC ensemble at
neutral pH. This remarkable result indicates that it is
possible to infer computationally much of the detailed
conformational properties of aS given only the mean Rg
of the ensemble and the robust knowledge-based potential
implemented in Rosetta.
To investigate whether this result is specific to Rosetta, or
also applies to other modern simulation techniques, we
performed extensive AAMD simulations on aS, which
faithfully reflected aS solution-state behavior at physiolog-
ical temperature, without any bias or post facto filtering. The
combination of Amber99SB and TIP4P-Ew solvent appears
to simulate the aS conformational ensemble with high
accuracy, in good agreement with the extensive results
from other groups (17–20,56,57) successfully applying
this parameter set to disordered proteins and peptides. The
high accuracy in reproducing the mean interresidue separa-
tions, as measured by smFRET, is especially noteworthy
given that previous MD studies (with other force fields
and solvent treatments) had to resort to temperatures 150–
300 K above physiological values to achieve similar agree-
ment with experiment (40,41). Recent corrections to the
Amber99SB force field (70) used with TIP3P solvent have
shown improved accuracy in predicting the folding behavior
of several model peptides and proteins (71,72), and in future
work we will test whether this parameter set also accurately
reproduces aS solution-state behavior.CONCLUSIONS
In this work, we have developed and validated a new, to our
knowledge, approach to effectively investigate the confor-
mational behavior of disordered proteins, using MC simula-
tions constrained by smFRET experiments. In particular, we
have shown that the global dimensions and polymer confor-
mational statistics of the model protein aS and tau can be
accurately determined from a relatively small number of
interresidue distance measurements, and produce ensembles
in excellent agreement with previous experimental studies,
as well as with the AAMD simulations in the case of aS.
Conversely, we have shown that recently developed protein
Conformational Ensembles of aS and Tau 1947energy functions make it possible to predict detailed
conformational properties and mean interresidue distances
of aS from its global dimensions, and that transient
charge-mediated contacts between the residues distant in
sequence may underlie the dynamic conformational fluctu-
ations of aS and tau suggested by our findings and others
(30,65,73,74).
The ECMC approach is much less computationally in-
tensive than simulation methods that predict IDP conforma-
tional ensembles with comparable accuracy, which become
rapidly more demanding as the size of the protein of interest
increases. For example, comparable AAMD studies on tau
would require simulation of a system at least an order of
magnitude larger in volume (to accommodate the greater
dimensions of tau), for a substantially longer period of
time (to sample the increased number of degrees of freedom
of the tau chain with a similar level of detail to aS). Given
typically available resources, the consequent computational
expense makes routine AAMD simulations of large IDPs
infeasible. ECMC could therefore serve as an efficient alter-
native strategy to characterize the detailed conformations of
diverse IDPs. ECMC based on smFRET measurements is
also well suited to the identification of high-affinity binding
partners of IDPs; this is potentially of broad pharmacolog-
ical relevance, given that IDPs may be effective drug targets
for a range of diseases (46). ECMC could therefore prove to
be a versatile probe of the effects of environmental factors,
drug-like small molecules, and biological ligands on IDP
conformations in health and disease.SUPPORTING MATERIAL
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